Microbot Medical shares surge 21.81% intraday after Emory University Hospital becomes first to adopt LIBERTY® Endovascular Robotic System.

Microbot Medical surged 21.81% intraday after announcing that Emory University Hospital became the first global adopter of its LIBERTY® Endovascular Robotic System, accelerating commercialization. The company specializes in robotic minimally invasive surgical devices, with the LIBERTY system being the first FDA-cleared single-use remote-controlled vascular robot. HC Wainwright & Co. reiterated a "Buy" rating and maintained a $12 price target for the stock.